Movmedix

What Movmedix does

Movmedix is a French medical device company headquartered in Arc-sur-Tille, France, specializing in the design, manufacture, and global distribution of synthetic ligaments for orthopedic and sports medicine applications. Founded in 1992 by Dr. Jacques-Philippe Laboureau as L.A.R.S. (Laboratoire d'Application et de Recherche Scientifique), the company was acquired by Huaxing HC fund in 2021 and rebranded to Movmedix on January 1, 2023. The company employs 11–50 people and manufactures in state-of-the-art cleanrooms in France under ISO 13485 quality systems.

The core product is the LARS (Ligament Advanced Reinforcement System) platform — a third-generation synthetic ligament made from biocompatible polyethylene terephthalate (PET) featuring patented "free fiber" technology with a dual-zone structural design (intra-osseous and intra-articular sections). The portfolio spans 11 anatomical indications across knee (ACL single/double bundle, PCL, MCL, patellar tendon), shoulder (ACJ, rotator cuff), foot & ankle (lateral ankle, Achilles tendon), and soft tissue applications, complemented by ISO 5832-3 titanium screws, ISO 5832-4 cobalt chromium staples, and a dedicated surgical instrument set. The LARS platform has been used in more than 250,000 patients globally across 36 countries with over 30 years of clinical history. A 4th-generation biomimetic ligament is in clinical investigation in Italy since 2022 in partnership with the I.R.T.A.L. Institute and Paris XIII University, and a 5th-generation bioresorbable ligament (Liga2Bio project) is in development with €6.4 million in Bpifrance funding as part of a €9 million project budget.

Movmedix generates revenue primarily through hardware sales of LARS implants via an authorized global distributor network, supplemented by medical education services through Movmedix Academy (including cadaver workshops, webinars, and faculty-led training). The China subsidiary represents the "heart of the business" with LARS Training Centers at hospitals in Beijing and Xiamen, while the rest of the world operates through territory-specific distributors. Reported revenue is "tens of millions of euros" growing at over 25% annually — well above the 7–8% sports medicine market — with +23% growth in 2024 and a +30% target for 2025. Pricing is in Euros with no public list price; following FDA 510(k) clearance for LARS ACJ in July 2026, the company is executing a phased U.S. market entry through strategic surgeon and sports medicine specialist partnerships.

Name

Movmedix

Legal name

Movmedix

Website

https://movmedix.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Movmedix is a French medical device company that designs and manufactures LARS synthetic PET ligaments for orthopedic and sports medicine surgeons worldwide, operating across 36 countries through distributors and a wholly-owned China subsidiary.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)

akta.pro secondary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Synthetic ligament implants
• Orthopedic medical devices
• Sports medicine products
• Ligament reconstruction systems
• Biocompatible PET grafts

Headquarters

HQ city

Arc-sur-tille

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Synthetic Ligament and Orthopedic Implant Sales: Sale of LARS synthetic ligament implants and complementary fixation systems (titanium screws, cobalt chromium staples) and surgical instruments to healthcare providers through distributor network globally.
2. Medical Education and Training Services: Movmedix Academy programs including hands-on cadaver workshops, live webinars, and surgical training sessions for orthopedic surgeons, supporting product adoption and surgeon education globally.

Go-to-market motion3 records

Distribution channels8 records

Marketing channels7 records

Core offering

Movmedix designs, manufactures, and sells synthetic ligament and tendon implants under the LARS (Ligament Advanced Reinforcement System) brand, made from biocompatible polyethylene terephthalate (PET) using patented free fiber technology. The portfolio covers reconstruction and reinforcement of knee (ACL, PCL, MCL, patellar tendon), shoulder (ACJ, rotator cuff), foot and ankle (lateral ankle ligament, Achilles tendon), and soft tissue injuries, complemented by titanium screws, cobalt-chromium staples, surgical instruments, and the Movmedix Academy medical education program for surgeons.

Product overview

Movmedix is a French medical device company specializing in synthetic ligament technology, offering a comprehensive portfolio of LARS (Ligament Advanced Reinforcement System) products. The core offering consists of synthetic ligament implants made from biocompatible polyethylene terephthalate (PET) for reconstruction and reinforcement of ligaments and tendons. The portfolio spans knee applications (LARS ACL Single/Double Bundle, LARS PCL, LARS MCL, LARS Patellar Tendon), shoulder applications (LARS ACJ, LARS Rotator Cuff), and foot & ankle applications (LARS Ankle Lateral, LARS Achilles Tendon), plus soft tissue reinforcement products. Each ligament line is complemented by dedicated fixation systems (titanium screws, cobalt chromium staples) and surgical instruments. The company also provides medical education through Movmedix Academy, featuring cadaver workshops and webinars. The LARS platform has over 30 years of clinical history with 11 anatomical indications and more than 250,000 patients treated globally.

Differentiator

Problem solved

Functional benefit

Brands

• LARS: Ligament Advanced Reinforcement System - synthetic ligament product line made from biocompatible polyethylene terephthalate (PET) for ligament reconstruction and reinforcement
• LARS Academy
• Movmedix Academy

Products and services

• LARS ACL - Single Bundle Synthetic PET ligament for reconstruction and reinforcement of the Anterior Cruciate Ligament using single-bundle technique; available in AC 80 L/R, AC 100 2BL/2BR, AC 120 BL/BR variants plus tubular ACTOR 8 and ACTOR 10 for autograft reinforcement. Targeted at orthopedic sports medicine surgeons.
• LARS ACL - Double Bundle Synthetic PET ligament for ACL reconstruction using double-bundle technique (AC 30 DB for reconstruction with graft; AC 40 DB, AC 50 DB, AC 60 DB for reconstruction only), leveraging free fiber technology to minimize torsion fatigue. For orthopedic sports medicine surgeons.
• LARS PCL Synthetic PET ligament for reconstruction and reinforcement of the Posterior Cruciate Ligament, available in single-bundle (PC 60, PC 80), double-bundle (PPLY 100), and tubular ACTOR 8/10 for autograft reinforcement. For orthopedic knee surgeons.
• LARS MCL Synthetic PET ligament (MCL 32) for reconstruction of the Medial Collateral Ligament, combining cylindrical intra-osseous wrap-knitted section, free fibers for natural mimicry, and flat extra-osseous section for tibial insertion; compatible with LARS titanium screws and staples.
• LARS ACJ Synthetic PET ligament (LAC 20, LAC 30 CK) for reconstruction of acute or chronic acromioclavicular joint dislocation (Rockwood grade III-V), featuring no coracoid drilling requirement and conical titanium screw fixation. For orthopedic shoulder surgeons.
• LARS Rotator Cuff Synthetic PET patch (CR 30/SB) for reinforcement of rotator cuff tendon native tissue in acute (less than three weeks) and chronic rotator cuff injuries, including large-massive tears. For orthopedic shoulder surgeons.
• LARS Ankle Lateral Synthetic PET ligament (LLEA 44) with Y-shaped double-bundle (three-branch) design for reconstruction of lateral ankle ligament to treat lateral ankle instability, passed into talus, calcaneus, and fibula tunnels. Incorporates free fibers technology to facilitate fibroblastic growth.

Quantifiable outcome

• More than 250,000 patients treated globally with LARS implants
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Premed Solutions (Premedsolution)coreChannel Partner/ Reseller/ Distributor · 1 February 2026Saudi Arabia distribution partner driving Middle East market expansion. Organized medical education training for over 30 healthcare professionals including orthopaedic, trauma, and sports medicine surgeons, with two dedicated symposia held at Riyadh Military Hospital.
• Device Technologies | AsiacoreChannel Partner/ Reseller/ Distributor · 1 October 2025Southeast Asia distribution partnership for Malaysia, Thailand, and Singapore. Device Technologies | Asia collaborated with Movmedix to organize hands-on surgical workshops at Siriraj Hospital in Thailand, training nearly 40 surgeons from over seven countries on knee and shoulder indications.
• I.R.T.A.L. Institute (Italy)coreStrategic or Co-development Partner · 1 July 2024Collaborative development partnership for LARS Generation 4 bioactive ligament. Prof. Cerulli, Dr. Tei, and Mr. Tiribuzi from I.R.T.A.L. Institute visited Movmedix to exchange insights on the Generation 4 product currently in clinical trial in Italy.
• Colombia Distribution PartnercoreChannel Partner/ Reseller/ DistributorMovmedix expanded into Colombia as its 29th country for LARS product registration and future sales, establishing a distribution partnership to serve the growing healthcare sector and increasing demand for advanced orthopedic treatments in Latin America.
• Sheng Wei MedicalcoreChannel Partner/ Reseller/ DistributorTaiwan distributor for LARS products, organizing sales team training (23 participants) and hands-on workshops led by Dr. Chang (Macau) on ACL, PCL, and MPFL techniques with 20 surgeons in attendance. Also facilitated online clinical presentation by Dr. Zhang Jin (Beijing Hospital).
• M.I.T. Italia SrlcoreChannel Partner/ Reseller/ DistributorOfficial distributor for Italy, collaborating with Movmedix to host cadaver workshop in Verona, training 20 surgeons on knee and shoulder techniques including ACL, PCL, and ACJ reconstruction.
• Zimmer BiometcoreChannel Partner/ Reseller/ DistributorDistributor in France, collaborating on the first edition of Bioskills Sports Medicine cadaver lab at CHU Dijon. Expert faculty included Pr Olivier Barbier, Dr Camille Choufani, and Dr Ludovic Labattut. Training covered PCL, ACL reinforcement, and meniscal sutures with 20 participants.
• Life Medical EquipmentcoreChannel Partner/ Reseller/ DistributorDistributor in the United Arab Emirates (Dubai). Organized cadaver training workshop on ACL reconstruction with LARS ligament for autograft augmentation at the 9th International Trauma Congress (ITC 2025). Faculty: Prof. Dr. Massimo Piracci from Medcare Hospital, Dubai.
• Paris XIII UniversitycoreStrategic or Co-development PartnerAcademic partnership for development of 4th generation biomimetic artificial ligament, initiated in 2016. Collaboration focused on creating a bioactive ligament that faithfully reproduces natural ligament structure and flexibility.
• Beijing and Xiamen Hospitals (China Training Centers)minorStrategic or Co-development PartnerLARS Training Centers established at two hospitals in Beijing and Xiamen, China, inaugurated by CEO Hervé Legrand. These facilities host training courses with 80 surgeons in attendance, advancing surgical education for LARS techniques in China.
• Faculty Experts NetworkminorStrategic or Co-development PartnerInternational network of key opinion leaders (KOLs) including Dr. Andrea Colombelli, Dr. Saverio Antonieri, Dr. Concari, and Dr. Candiotto (Italy); Prof. Gliatis and Dr. Plessas (Greece); Prof. Al-Dadah (UK); Dr. Aman Singh and Dr. David Sime (Australia); Dr. Chang (Macau); Dr. Matteo Rizzo (Switzerland); Dr. Michel Leroux (Canada); Dr. Joshua Petterwood (Australia); Prof. Lennard Funk (UK); and Prof. Massimo Berruto (Italy).

Scale indicators15 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Integra LifeSciences: Integra LifeSciences has expanded into regenerative and sports medicine, including tendon and ligament repair products, through both organic R&D and acquisitions. Its tissue technologies segment overlaps thematically with Movmedix's Gen 4 biomimetic and Gen 5 bioresorbable pipeline, representing adjacent innovation in the same category.

Broad incumbents

• Johnson & Johnson (DePuy Synthes Mitek Sports Medicine): DePuy Synthes Mitek Sports Medicine is a leading global player in arthroscopic sports medicine, offering soft tissue repair, ACL/PCL reconstruction, and shoulder products that overlap with Movmedix's portfolio. As part of J&J MedTech, it has the resources and scale to shape surgeon preference in U.S. sports medicine.
• Conmed: Conmed is a U.S.-based medical device company with a focused sports medicine portfolio including ACL/PCL reconstruction grafts, anchors, and arthroscopic instruments. Its presence in the sports medicine space makes it a comparable competitor to Movmedix, particularly in shoulder and knee indications.
• Smith+Nephew: Smith+Nephew operates a large sports medicine franchise (formerly ArthroCare) offering grafts, anchors, and soft tissue repair products across ACL, rotator cuff, and ACJ indications. Its global commercial reach and surgeon relationships make it a direct competitive threat to Movmedix's U.S. launch.
• Arthrex: Arthrex is the dominant global sports medicine and soft tissue repair company, offering a broad portfolio of ACL/PCL/ACJ reconstruction grafts, fixation, and instrumentation that directly overlaps Movmedix's sports medicine indications. As the largest player in the space, Arthrex will be the principal competitor as Movmedix enters the U.S. market.
• Zimmer Biomet: Zimmer Biomet is one of the world's largest orthopedic medical device companies and already acts as Movmedix's distributor in France. Its broad sports medicine offering (ACL, shoulder, extremities) overlaps with LARS indications, and the existing partnership underscores the strategic adjacency between the two companies.
• Stryker: Stryker's sports medicine division offers a broad portfolio of soft tissue repair implants, fixation devices, and biologics that overlap with LARS indications including ACL reconstruction and shoulder repair. As a top-three global orthopedic medical device company, Stryker represents both a competitor and a potential strategic acquirer.

Direct peers

• Artelon: Artelon is a Swedish medical device company specializing in dynamic stabilization technologies for ligaments and tendons, with products in sports medicine and foot/ankle reconstruction. Its focus on soft tissue reinforcement in ligament indications makes it a niche direct competitor to LARS.
• Xiros (Neoligaments): Xiros, through its Neoligaments division, is the most direct synthetic ligament competitor to LARS, marketing polyester and other artificial ligaments for ACL, PCL, and other ligament reconstructions worldwide. The two companies compete head-to-head in sports medicine synthetic ligament indications across multiple geographies.
• Cousin Biotech: Cousin Biotech is a French medical device manufacturer producing surgical implants for spine, orthopedic, and ligament applications, including artificial ligaments. Its shared French heritage and overlapping orthopedic implant portfolio make it a direct regional peer to Movmedix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@lars-movmedix6689/videos
• LinkedInlinkedin.com/company/l-a-r-s-laboratoire-d-application-et-de-recherche-scientifique

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Movmedix